We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to select compliance points for the assessment of risks to groundwater from land contamination.
The government responds to a report by the Advisory Council on the Misuse of Drugs and commissions Part 2 of work on barriers to research.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Receptor recognition and binding is the first step of viral infection and a key determinant of host specificity.
How to carry out a groundwater risk assessment as part of an application for an environmental permit.
This report provides an updated harms assessment to the ACMD's previous reports on synthetic cannabinoid receptor agonists.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Associations of inherited blood disorders and hemoglobin, ferritin and soluble transferrin receptor concentrations
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Volume 53 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
The objective of this study was to investigate H9N2 haemagglutinins using 2 well-known correlates for human adaption
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).